Abstract:In exploring nature's potential in addressing diabetes-related conditions, this study investigates the therapeutic capabilities of 3-formyl chromone derivatives. Utilizing in silico methodologies, we focus on 6-substituted 3-formyl chromone derivatives (1–16) to assess their therapeutic potential in treating diabetes. The research examined the formyl group at the chromone's C-3 position. ADMET, biological activities, were conducted along with B3LYP calculations using 3 different basis sets. The analogues were analyzed based on their parent structure obtained from PubChem. The HOMO–LUMO gap confirmed the bioactive nature of the derivatives, NBO analysis was performed to understand the charge transfer. PASS prediction revealed that 3-formyl chromone derivatives are potent aldehyde oxidase inhibitors, insulin inhibitors, HIF1A expression inhibitors, and histidine kinase. Molecular docking studies indicated that the compounds had a strong binding affinity with proteins, including CAD, BHK, IDE, HIF-α, p53, COX, and Mpro of SARS-CoV2. 6-isopropyl-3-formyl chromone (4) displayed the highest affinity for IDE, with a binding energy of − 8.5 kcal mol −1 . This result outperformed the affinity of the reference standard dapagliflozin (− 7.9 kcal mol −1 ) as well as two other compounds that target human IDE, namely vitexin (− 8.3 kcal mol −1 ) and myricetin (− 8.4 kcal mol −1 ). MD simulations were revealed RMSD value between 0.2 and 0.5 nm, indicating the strength of the protein–ligand complex at the active site.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the potential therapeutic capabilities of 6 - substituted 3 - formylchromone derivatives as anti - diabetic drugs. Specifically, the research evaluated the bioactivity and pharmacological properties of these compounds in the treatment of diabetes by using computer - simulation methods (such as molecular docking, molecular dynamics simulation, etc.). The research particularly focused on the formyl group at the C - 3 position on the 3 - formylchromone ring and carried out a detailed analysis of 16 6 - substituted 3 - formylchromone derivatives through different computational chemistry methods (such as density functional theory calculations at the B3LYP theoretical level). ### Main research contents: 1. **Structure optimization and property calculation**: Three basis sets, B3LYP/6 - 31G(d,p), B3LYP/6 - 311G(d,p) and B3LYP/6 - 311++G(d,p), were used to perform geometric optimization and frequency calculation on 16 6 - substituted 3 - formylchromone derivatives to verify their stability. 2. **Frontier orbital analysis**: The energy gap (Egap) between the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) was calculated to evaluate the chemical reactivity and stability of the compounds. 3. **ADMET property prediction**: The absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of the compounds were evaluated through tools such as swissADME and AdmetSAR. 4. **Molecular docking**: The AutoDock Vina software was used to perform molecular docking of 16 compounds with multiple target proteins (such as insulin - degrading enzyme IDE, SARS - CoV - 2 main protease Mpro, etc.) to evaluate their binding affinities. 5. **Molecular dynamics simulation**: The GROMACS software was used to perform molecular dynamics simulation on selected protein - ligand complexes to further verify their stability and interaction. ### Key findings: - **HOMO - LUMO energy gap**: The research found that the type of 6 - substituent (electron donor or electron acceptor) significantly affects the HOMO - LUMO energy gap of the compounds, thereby affecting their chemical reactivity and stability. - **Molecular docking results**: The binding energy of 6 - isopropyl - 3 - formylchromone (compound 4) with insulin - degrading enzyme IDE is - 8.5 kcal/mol, which is better than that of the reference drug dapagliflozin (- 7.9 kcal/mol) and other known IDE inhibitors. - **Molecular dynamics simulation**: The results of MD simulation show that the root - mean - square deviation (RMSD) values of the protein - ligand complexes are between 0.2 and 0.5 nm, indicating that the complexes have good stability at the active sites. ### Conclusion: This research systematically evaluated the anti - diabetic potential of 6 - substituted 3 - formylchromone derivatives, especially their potential as insulin - degrading enzyme IDE inhibitors, through comprehensive computational chemistry methods. The research results provide an important theoretical basis and experimental evidence for the development of new anti - diabetic drugs.

Investigating the potential of 6-substituted 3-formyl chromone derivatives as anti-diabetic agents using in silico methods

Innovation of 6-sulfonamide-2H-chromene derivatives as antidiabetic agents targeting α-amylase, α-glycosidase, and PPAR-γ inhibitors with in silico molecular docking simulation

Discovery of novel 6-(piperidin-1-ylsulfonyl)-2 H -chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus

Synthesis of the chromone‐thiosemicarbazone scaffold as promising α‐glucosidase inhibitors: An in vitro and in silico approach toward antidiabetic drug design

Synthesis, structure of the N-(Alkyl/Arylsulfonyl) substituted 5-(Bromo/Iodo)-3-methylindazoles and bioactivity screening against some of the biochemical targets linked to type 2 diabetes mellitus

Integrative bioinformatic and experimental analysis of benzoylbenzodioxol derivatives: hypoglycemic potential in diabetic mice

Synthesis, Characterizations, Anti-Diabetic and Molecular Modeling Approaches of Hybrid Indole-Oxadiazole Linked Thiazolidinone Derivatives

Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents

Synthesis, characterization and molecular modeling approach of hybrid pyrazole based thiazolidinone derivatives: An estimation and inhibition of diabetes mellitus

Cheminformatics identification of modulators of key carbohydrate-metabolizing enzymes from C. cujete for type-2 diabetes mellitus intervention

Synthesis and molecular docking studies of new aryl imeglimin derivatives as a potent antidiabetic agent in a diabetic zebrafish model

In Silico Exploration of Isoxazole Derivatives of Usnic Acid: Novel Therapeutic Prospects Against α-Amylase for Diabetes Treatment

Investigating Novel Thiophene Carbaldehyde Based Thiazole Derivatives as Potential Hits for Diabetic Management: Synthesis, In Vitro and In Silico Approach

Molecular docking, chemo-informatic properties, alpha-amylase, and lipase inhibition studies of benzodioxol derivatives

Quinoline-based Schiff bases as possible antidiabetic agents: ligand-based pharmacophore modeling, 3D QSAR, docking, and molecular dynamics simulations study

Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting α-amylase, and α-glucosidase: synthesis, molecular docking, and ADMET studies

Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α -glucosidase and α -amylase, computational docking analysis and molecular dynamics simulations

Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes

Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation

Design, synthesis, molecular dynamic simulation, DFT analysis, computational pharmacology and decoding the antidiabetic molecular mechanism of sulphonamide-thiazolidin-4-one hybrids

Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment